|
|
 |
|
Viewing report
|
|
|
|
China Pharmaceutical Industry 1H11
Emerging Markets Direct, Jan 2011, Pages: 24
'China Pharmaceutical Industry 1H11' includes an overview of China’s pharmaceutical industry, a “pharmerging” market that is likely to grow into the third-largest pharmaceutical market in the world by 2011. Part 1 of the report contains a brief outline of the industry in 2009, explaining the structure and size of the pharmaceutical industry. It also introduces the government policies that have influenced the industry and the various issues that the industry copes with.
Part 2 of the report includes a description of the major pharmaceutical segments, with the current trends and happenings present in the segment. A concise global merger and acquisition outline and market outlook are also included in this part.
Part 3 of the report lists the top 100 China’s pharmaceutical enterprises for 2009. Because the industry is very fragmented, this report only includes a few of the leading players with their current developments and three-year financial highlights. The leading players introduced in this report are Harbin Pharmaceutical Group Co., Ltd., Northeast Pharmaceutical Co., Ltd., North China Pharmaceutical Co., Ltd., and Beijing Double-Crane Pharmaceutical Co., Ltd.
A comparative matrix of the companies’ financial highlights is incorporated in the report with a SWOT analysis of the industry.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
